series-b
Stage
1
Investors
About
Nura Bio is developing neuroprotective therapies targeting fundamental pathways of axon degeneration and neuroimmune regulation to treat neurological diseases.
Explore Nura Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.